Skip to main content
Clinical Trials/CTRI/2020/09/027788
CTRI/2020/09/027788
Completed
Phase 2

Effect of a home-based pulmonary rehabilitation program on functional capacity and health related quality of life in persons with Interstitial Lung Disease- A Randomized Controlled Trial

Revati Amin0 sites106 target enrollmentTBD

Overview

Phase
Phase 2
Intervention
Not specified
Conditions
Health Condition 1: J00-J99- Diseases of the respiratory system
Sponsor
Revati Amin
Enrollment
106
Status
Completed
Last Updated
last year

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
TBD
End Date
January 8, 2024
Last Updated
last year
Study Type
Interventional

Investigators

Sponsor
Revati Amin

Eligibility Criteria

Inclusion Criteria

  • Physician and radiologically (HRCT) diagnosed interstitial lung disease patients.
  • Clinically stable and ambulant with or without assistive aids.
  • Able to perform 6 MWT and maintain SPO2\= 80% during the test.
  • Supplemental oxygen users.

Exclusion Criteria

  • Those unable to ambulate.
  • Recent myocardial infarction, unstable angina, acute pulmonary oedema, acute myocarditis or pericarditis, severe rhythm disorders, non\-ambulatory rheumatic diseases, severe pulmonary artery hypertension.
  • Acute exacerbation of interstitial lung disease\- dyspnea grade 4\.
  • Those unable to follow written and verbal commands.
  • Musculoskeletal conditions like severe osteoarthritis, disk prolapse, recent fractures and recent joint replacement surgeries if any that prevent gentle exercises.
  • Neurological and orthopedic conditions impairing mobility\- stroke, spinal cord injury.

Outcomes

Primary Outcomes

Not specified

Similar Trials